Back to Annual Meeting Page		American Public Health Association 133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA

Abstract #116603

Anne Helene Skinstad, Ph D, Department of Community and Behavioral Health, College of Public Health, University of Iowa, E 107 General Hospital, Iowa, IA 52242, 319-384-5394, anne-skinstad@uiowa.edu, Anne Wallis, PhD, Iowa Center for Evaluation Research, Dept. of Community & Behavioral Health, The University of Iowa, College of Public Health, 4258 Westlawn, The University of Iowa, Iowa City, IA 52242, Keri L. N. Mercer, MPH, CHES, Iowa Center for Evaluation Research, Department of Community and Behavioral Health, College of Public Health, The University of Iowa, 4256 Westlawn, The University of Iowa, Iowa City, IA 52242, and Maurine A. Orwa, M P H, CHES, Department of Communication Studies, University of Iowa, 105 Becker Communication Studies Building, Iowa, IA 52242.

The Prairielands Addiction Transfer Technology Center (PATTC) provided clinical supervision to three training programs to encourage providers to implement evidence-based approaches to substance abuse treatment. Three separate training programs were conducted and evaluated for Iowa practitioners (1) to improve diagnosis and treatment of co-occurring disorders (2) to improve treatment success for parenting women through a curriculum designed to support them as parents; (3) to improve treatment for women with post-traumatic stress disorder. In all three evaluations, we found that evidence-based programs were only partially implemented. Lack of fidelity to procedures was attributable to: (1) perception of clinicians that programs were not appropriate for the unique issues of Iowan women, particularly rural women; (2) inconsistent commitment on the part of treatment center management to faithful program implementation; and (3) staff turnover was so frequent that the staff who received training were not always available to complete or repeat programs.

Learning Objectives: At the conclusion of the session, the participant in this session will be able to

• Discuss the use of clinical supervision in the dissemination of empirically supported substance abuse treatments.
• Analyze the different aspects of clinical supervision that work effectively and those that don’t.

Presenting author's disclosure statement:

I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.